Back to all news

Deep Learning CT Muscle Segmentation Enhances Sarcopenia Detection in COPD

AuntMinnieIndustry

A deep learning model for CT-based 3D pectoralis muscle segmentation outperforms standard 2D techniques in assessing muscle loss among COPD patients.

Key Details

  • 1Researchers compared automated 3D pectoralis muscle volume (PMV) segmentation to traditional 2D muscle area (PMA) analysis using CT scans.
  • 2The study included 1,235 participants (634 with COPD, 601 controls) from the CanCOLD cohort.
  • 3The U-Net model achieved Dice similarity coefficients of 0.94 (training/validation), 0.93 (internal test), and 0.92 (external test) for PMV segmentation.
  • 4Both PMA and PMV were significantly lower in COPD patients (p < 0.05), but PMV correlated more strongly with FEV1, Dlco, and VO2 clinical measures.
  • 5Authors recommend PMV as a surrogate marker for muscle mass and comorbid sarcopenia in COPD and call for normative reference studies.

Why It Matters

Automating muscle mass assessment from routine chest CTs may enable early identification of sarcopenia in COPD patients, facilitating targeted interventions and improved prognostication. This highlights an expanding role for AI in quantitative radiology beyond traditional pulmonary imaging.

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.